top of page
Cerca

Validation trial and further development (05/2022)

Our 800 patient validation trial is entering the final phase of inclusion and the first preliminary results are expected in August. In the meantime we are in discussion with several potential development partners. Jack van Lint our CEO will be visiting Digestive Disease Week 2022 in San Diego this weekend so if you are there reach out to him!




Comments

Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
bottom of page